echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > 4 videos, walk into the latest progress in the treatment of refractory gout!

    4 videos, walk into the latest progress in the treatment of refractory gout!

    • Last Update: 2022-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *Only for medical professionals to read and reference, there are a lot of dry goods, waiting for you to see! Refractory gout is the recurrent attack of acute gouty arthritis, which is characterized by the fact that conventional doses of uric acid-lowering drugs are difficult to make the blood uric acid reach the standard, manifested as chronic polyarthritis, destructive arthritis with tophi formation and/or uric acid Kidney stones
    .

    With the increasing incidence of gout, patients with refractory gout are more and more common
    .

    Today, let's follow Professor Zhang Xuewu from the Department of Rheumatology and Immunology, Peking University People's Hospital, to learn the latest progress in the treatment of refractory gout~ "Self-introduction" of refractory gout, the choice of uric acid-lowering drugs American College of Rheumatology Guidelines for gout management ( 2020 edition) Interpretation of new ideas that are different from the guidelines Copyright statement This article is original If you need to reprint, please contact the authorization - End - The medical community strives for the accuracy and reliability of its published content when it is approved, but does not regard the timeliness of the published content and the quotations Make any promises and guarantees for the accuracy and completeness of the information (if any), and do not assume any responsibility for the outdated content, possible inaccuracies or incompleteness of the cited information
    .

    Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
    .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.